1700 patients register to receive new hepatitis C drug

Thursday 18-09-2014 04:57 PM
1700 patients register to receive new hepatitis C drug

A nurse vaccinates a would-be pilgrim against H1N1 in a health centre in Cairo, November 8, 2009, ahead of the annual pilgrimage to Mecca. Egypt received the second batch of H1N1 vaccine from Britain in early November, local Nile TV reported. REUTERS/Asmaa Waguih

By

CAIRO, Sept 18 (Aswat Masriya) - Around 1700 patients registered on the Health Ministry's website to receive a cure for hepatitis C (HCV) on Thursday, Gamal Esmat, member of the Egyptian National Committee on Viral Hepatitis told Aswat Masriya in a phone interview. 

Esmat said that the number of registrations is constantly increasing to acquire the new hepatitis C pill Sovaldi. The ministry opened the online registration on Thursday morning.

Egypt's government signed in July an agreement with the U.S.'s Gilead company to sell its Sovaldi treatment to Egyptians for 1% of its price. 

The course of medication will  last for almost eight months, starting September 18 until July 14, according to the health ministry. 

Egypt has the world's highest prevalence of the virus that can be spread through blood and often via contaminated needles.

facebook comments